Bradley L. Campbell - Jun 21, 2022 Form 4 Insider Report for AMICUS THERAPEUTICS, INC. (FOLD)

Role
Chief Operating Officer, Director
Signature
/s/ Christian Formica, Attorney-in-Fact
Stock symbol
FOLD
Transactions as of
Jun 21, 2022
Transactions value $
-$106,173
Form type
4
Date filed
6/22/2022, 07:01 PM
Previous filing
Mar 22, 2022
Next filing
Jul 6, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FOLD Common Stock Options Exercise $57.9K +16.4K +2.38% $3.53 706K Jun 21, 2022 Direct
transaction FOLD Common Stock Sale -$164K -16.4K -2.32% $10.00 690K Jun 21, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FOLD Stock Options (right to buy) Options Exercise $0 -16.4K -33.32% $0.00 32.8K Jun 21, 2022 Common Stock 16.4K $3.53 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2 All of the options were fully vested and exercisable as of the transaction date.